Project Grant R25CA298910
Award Date 5/1/26
Completion Date 4/30/31
Dollars Obligated $141K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94305, USA
Similar Awards
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a Project Grant of $119,172.00 under the Cancer Research Manpower program (CFDA 93.398) to support research addressing therapeutic response in non-small cell lung cancer (NSCLC). The project, initiated August 1, 2025, and completing July 31, 2027, focuses on developing computational approaches to integrate multi-modal and multi-omics biomedical datasets for improved...
- Federal Project Grant Award Summary The Leland Stanford Junior University received a $135,774 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) on July 10, 2025, with a completion date of June 30, 2027. This award supports research training and investigation into tumor suppressor genes (TSGs) and the overdominant model of tumor suppression in oncogenic KRAS-driven lung adenocarcinoma. The research employs advanced molecular and...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a Project Grant of $133,598.00 under the Cancer Research Manpower program (CFDA 93.398) on June 23, 2025, with completion anticipated by May 31, 2027. This award supports research aimed at developing improved chemoprevention strategies for Familial Adenomatous Polyposis (FAP), a hereditary condition characterized by polyp formation and elevated cancer risk. The principal...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded $113,147 to The Leland Stanford Junior University on July 3, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support a five-year career development program for Dr. Chris McGinnis, Ph.D. This Project Grant funds a mentored postdoctoral research training and career development initiative designed to prepare Dr. McGinnis for an independent research career in cancer immunology. The award supports Dr. McGinnis's...
- Federal Project Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a $368,294 Project Grant effective September 1, 2025, through August 31, 2028, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394). The research focuses on developing next-generation platforms for interrogating T-cell receptor (TCR) specificity to identify and detect peptide-MHC tumor antigens. Stanford will optimize two complementary technological approaches: (1)...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a Project Grant of $642,732 under the Cancer Cause and Prevention Research program (CFDA 93.393) beginning August 1, 2025, with a completion date of July 31, 2030. The award supports research to unravel heterogeneity in endometrial cancer through integrated single-cell genotype-phenotype mapping. The project addresses the critical need to refine molecular classification, improve...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a $584,521 Project Grant on August 8, 2025, under the Cancer Treatment Research program (CFDA 93.395) to investigate subclonal determinants of radiation response in soft tissue sarcomas. The research will deliver three primary products: (1) identification and validation of epigenetic changes, including DNA methylation and chromatin accessibility alterations, that confer radioresistance to...
- Federal Grant Award Summary The National Cancer Institute awarded Sloan-Kettering Institute for Cancer Research a Project Grant totaling $323,860 under the Cancer Research Manpower program (CFDA 93.398), effective August 18, 2025, with completion by April 30, 2028. This award supports investigative research to elucidate the role of mutagenic DNA repair mechanisms, specifically microhomology-mediated end joining (MMEJ), during cancer cell persistence and the development of acquired drug...
- Federal Project Grant Summary The National Institutes of Health (NIH) Office of the Director, under the Trans-NIH Research Support program (CFDA 93.310), awarded Stanford University a $1,033,055 Project Grant effective September 8, 2025, with a completion date of August 31, 2030. This research initiative focuses on developing therapeutic strategies to target cancer metastasis by inhibiting curvature-induced kinase activation. The project aims to unravel the molecular mechanisms by which...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Stanford University a Project Grant of $431,970 on April 7, 2025, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and pilot-test a culturally adapted behavioral intervention for South Asian breast cancer survivors and their family caregivers. The primary deliverable is South Asian Family Approaches to Disease (SAFAD), a theoretically grounded, dyadic self-management intervention designed to...